EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer’s Disease

Xue-Min Cui, Wang Wang, Lin Yang, Bao-Wen Nie, Qian Liu, Xiao-Hui Li, Dong-Xiao Duan

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xue-Min Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Neurobiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Eleutherococcus, Alzheimer Disease, Cognitive Dysfunction, Saponins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Province Science and Technology Research Project, China National Natural Science Foundation Youth Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive degenerative disease of the nervous system that affects older adults. Its main clinical manifestations include memory loss, cognitive dysfunction, abnormal behaviour, and social dysfunction. Neuroinflammation is typical in most neurodegenerative diseases, such as AD. Therefore, suppressing inflammation may improve AD symptoms. This study investigated the neuroprotective effects of Acanthopanax senticosus saponins (ASS) in an AD model induced by streptozotocin (STZ). Here, we characterised a rat model of STZ-induced AD with the parallel deterioration of memory loss and neuroinflammation. Following the end of the treatment with ASS (50 mg/kg for 14 consecutive days), behavioural tests (Morris water maze test, Y-maze test) were performed on the rat, and the molecular parameters (DAPK1, Tau5, p-Tau, NF-κB, IL-1β, TNF-α, and NLRP3) of the rat hippocampus were also assessed. We demonstrated that ASS, which has potent anti-inflammatory effects, can reduce neuroinflammation and prevent cognitive impairment. In the water maze test, ASS-treated groups exhibited significantly increased average escape latency (p < 0.05), the percentage of stay in the target quadrant (p < 0.05), and the number of times each group of rats crossed the platform (p < 0.05) compared to the negative control. And ASS could reduce the phosphorylation of the Tau protein (p < 0.001) and death-associated protein kinase 1 (DAPK1, p < 0.001) in the hippocampal tissue, improving cognitive impairment in STZ-treated rats by suppressing the inflammatory response; the molecular analysis showed a significant reduction in pro-inflammatory markers like NLRP3, IL-1β, TNF-α, and NF-κB (p < 0.001). It was also discovered that the NF-κB inhibitor SN50 had the same effect. Therefore, the present study used ASS through its anti-inflammatory effects to prevent and treat AD. This study highlights the potential efficacy of ASS in alleviating cognitive dysfunction in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EleutherococcusAlzheimer DiseaseCognitive DysfunctionSaponinsNeuroprotective AgentsAnimalsRatsMaleHippocampusDisease Models, Animaltau ProteinsMaze LearningNF-kappa BStreptozocin

Stichwörter der Autor:innen

Acanthopanax senticosus saponinsAlzheimer’s diseaseTau proteincognitive declineinflammation

Substanzen

SaponinsNeuroprotective Agentstau ProteinsNF-kappa BStreptozocin

Autor:innen und Institutionen

  • Department of Physiology and Neurobiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Förderung

  • Henan Province Science and Technology Research Project
  • China National Natural Science Foundation Youth Fund

Zitieren

APA

Cui, X. M., Wang, W., Yang, L., Nie, B. W., Liu, Q., Li, X. H., & Duan, D. X. (2025). Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083715

Vancouver

Cui XM, Wang W, Yang L, Nie BW, Liu Q, Li XH, et al. Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083715

BibTeX
@article{Cui2025,
  author = {Cui, Xue-Min and Wang, Wang and Yang, Lin and Nie, Bao-Wen and Liu, Qian and Li, Xiao-Hui and Duan, Dong-Xiao},
  title = {Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083715}
}
Kostenlos starten →